Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Care Delivery & Psychedelic Facilitation
Care Delivery & Psychedelic Facilitation
Psychedelic Healthcare ImplementationPayer & Reimbursement Stakeholders

pan-Canadian Pharmaceutical Alliance (pCPA)

Canadian pan-jurisdictional payer negotiation body that coordinates joint drug price negotiations for public plans, including completed negotiations for Spravato (esketamine).

Reimbursement & Market Access Snapshot

Insurance Payers & Reimbursement Specialists

Service Model

Payer Negotiation Body

Jurisdiction

National

Coverage

1 country

Last Verified

Apr 8, 2026

Focus Areas

Reimbursement NegotiationCoverage Policy DesignFormulary & Access Criteria

Evidence Requirements

Clinical Efficacy EndpointsComparative EffectivenessCost-EffectivenessBudget Impact

Market Access Notes

pCPA coordinates reimbursement negotiations across participating public drug plans and has a publicly listed closed negotiation for Spravato.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Primary Access Link

Source Evidence

pCPA - Spravato Negotiation Record

https://www.pcpacanada.ca/negotiation/21368

pCPA - About

https://www.pcpacanada.ca/about

Quick Facts

Website
Visit